Search Login Register

Central Nervous System Cavernous Hemangioma Summary

Description: A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.

Also Known As: Hemangioma, Cavernous, Central Nervous System; Cavernous Angioma, Central Nervous System; Cavernous Hemangioma of Brain; Cavernous Hemangioma, Extracerebral; Cavernous Hemangioma, Intracerebral Show All >>

Networked: 10 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Central Nervous System Cavernous Hemangioma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Retinaldehyde (Retinal) : 2 results : IBA
  2. Gadolinium DTPA (Magnevist) : 1 result : FDA 2
  3. Phenytoin (Dilantin) : 1 result : FDA 9 Generic
  4. Insulin (Novolin) : 1 result : FDA 2
  5. Hemosiderin : 1 result : IBA

Diseases Related to Central Nervous System Cavernous Hemangioma

  1. Germinoma
  2. Medulloblastoma
  3. Cavernous Hemangioma (Cavernous Angioma)
  4. Type 1 Diabetes Mellitus (Autoimmune Diabetes)

Key Therapies for Central Nervous System Cavernous Hemangioma

Efficacy Chart >>
  1. Radiotherapy : 3 results
  2. Cranial Irradiation : 1 result
  3. Aftercare (After-Treatment) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.